Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRPO | US
0.13
0.56%
Healthcare
Diagnostics & Research
30/06/2024
05/06/2026
23.49
23.49
23.93
22.98
Precipio Inc. a healthcare solutions company provides diagnostic products reagents and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven Connecticut.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
45.2%1 month
51.7%3 months
65.6%6 months
61.0%-
15.43
0.82
0.10
0.07
-1.15
0.59
-
-4.30M
34.82M
34.82M
-
-27.22
-
25.70
-29.22
1.07
0.63
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.87
Range1M
11.96
Range3M
11.96
Rel. volume
0.66
Price X volume
538.25K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 11.3 | 36.40M | -3.00% | n/a | 26.85% |
| Aclarion Inc | ACON | Health Information Services | 3.57 | 35.86M | 1.13% | n/a | 47.32% |
| Biomerica Inc | BMRA | Diagnostics & Research | 2.12 | 35.66M | -1.17% | n/a | 13.22% |
| MDxHealth SA | MDXH | Diagnostics & Research | 0.5659 | 26.76M | -5.68% | n/a | -643.01% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.459 | 24.98M | -5.94% | n/a | 159.92% |
| bioAffinity Technologies Inc. | BIAF | Diagnostics & Research | 1.73 | 23.34M | -7.98% | n/a | 40.20% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 0.8389 | 22.28M | -7.36% | n/a | 0.00% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.4003 | 18.27M | -11.24% | n/a | 117.50% |
| XWEL | XWEL | Diagnostics & Research | 1.36 | 7.15M | -2.16% | n/a | 126.14% |
| Trinity Biotech plc | TRIB | Diagnostics & Research | 0.6675 | 6.32M | -2.43% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Reading International Inc | RDI | Media - Diversified | 1.18 | 33.31M | 0.85% | n/a | 4054.78% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 14.90M | -4.67% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.428 | 8.27M | 2.39% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.32 | 3.37M | -13.16% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.3876 | 213.57K | -7.71% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.15 | 12.67 | Cheaper |
| Ent. to Revenue | 0.59 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.82 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 65.57 | 59.59 | Par |
| Debt to Equity | 0.10 | -14.36 | Expensive |
| Debt to Assets | 0.07 | 0.34 | Cheaper |
| Market Cap | 34.82M | 13.71B | Emerging |